Fundraising Fox

Anodyne Nanotech

Boston, US · Founded 2019 · Delaware corporation · 3 known investors

Healthtech

Founders & leadership

LJLOMBARDO JAKE
LOMBARDO JAKEinExecutive
VL
Vikram LambaNamed on SEC filing
GP
Georgios PapastergiouNamed on SEC filing
KT
Konstantinos TzortzakisNamed on SEC filing
JL
Jake LombardoNamed on SEC filing
HR
HOJATOLLAH REZAEI NEJADNamed on SEC filing
LK
LAMPROS KOURTISNamed on SEC filing

Board

MS
Michael SingerBoard director
AG
ACHILLEAS GRAVANISBoard director

Investors · 3

Also in the syndicate · 3

Evercurious VCleadRelativity Healthcare PartnersVelocity Partners VClead

Reported raises · per SEC filings

Form D private placements

$16M disclosed across 3 rounds · 2020–2026

▶$12.6MraisedJun 2026 · 47 investors · Other Health Care
Rule 506(b)
Anodyne Nanotech Closed a $12.6 Million Series A to Advance Once-Weekly GLP-1 Patch into Phase I Clinical Trialsbusinesswire.com · Jun 2026 · press releaseAnodyne Nanotech Raises $12.6M in Series A Fundingfinsmes.com · Jun 2026
Officers, directors & promoters on the filing
  • Michael SingerDirector
  • Vikram LambaDirector
  • Georgios PapastergiouDirector
  • Konstantinos TzortzakisExecutive Officer, Director
  • Jake LombardoExecutive Officer, Director
Offering amount
$17.3M
Amount sold
$12.6M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2021 · 15 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • MICHAEL SINGERDirector
  • HOJATOLLAH REZAEI NEJADExecutive Officer
  • KONSTANTINOS TZORTZAKISExecutive Officer, Director
  • LOMBARDO JAKEExecutive Officer
  • LAMPROS KOURTISDirector
  • ACHILLEAS GRAVANISDirector
Offering amount
$2M
Amount sold
$2M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedAug 2020 · 20 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • KONSTANTINOS TZORTZAKISExecutive Officer, Director
  • ACHILLEAS GRAVANISDirector
  • LOMBARDO JAKEExecutive Officer
  • LAMPROS KOURTISDirector
  • MICHAEL SINGERDirector
  • HOJATOLLAH REZAEI NEJADExecutive Officer
Offering amount
$2.3M
Amount sold
$1.5M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Anodyne Nanotech has filed a notice of an exempt offering of securities to raise $17,259,023.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Anodyne Nanotech has filed a notice of an exempt offering of securities to raise $17,259,023.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Anodyne Nanotech has raised $12,600,000.00 in new Series A funding - intelligence360intelligence360.news · Jul 2026Anodyne Nanotech has raised $12,600,000.00 in new Series A funding - intelligence360intelligence360.news · Jul 2026Anodyne Nanotech Raises $12.6 Million Series A To Advance Once-Weekly GLP-1 Patchpulse2.com · Jun 2026Anodyne Nanotech Raises $12.6M in Series A Fundingfinsmes.com · Jun 2026Anodyne Nanotech Closed a $12.6 Million Series A to Advance Once-Weekly GLP-1 Patch into Phase I Clinical Trialsbusinesswire.com · Jun 2026 · press releaseAnodyne Nanotech Closes $4.2M Seed Financing - FinSMEsfinsmes.com · May 2021

Frequently asked questions

How much funding has Anodyne Nanotech raised?
Anodyne Nanotech has disclosed $16M raised across 3 rounds.
Where is Anodyne Nanotech headquartered?
Anodyne Nanotech is headquartered in Boston, US.